— Ritu Mohanka, vice president of strategy & development EMEA at Glint (part of LinkedIn), is now the managing director and head of EMEA at Seattle startup Syndio.
Mohanka has prior experience at Kenexa Inc. (which later became IBM Smarter Workforce) and was named on the EMpower Top 100 Ethnic Minority Senior Executive list in 2021. She led the diversity, inclusion, and belonging initiative at Glint to address discrimination in hiring practices.
Syndio provides a software solution that uses data science to promote equitable workplaces through monitoring pay and other metrics. Syndio raised $50 million in September. The company is now expanding to the UK and EMEA market.
“Diversity, equity, and fair pay are intertwined — and unless you address root causes of inequities, you may not end up better off than at the start,” Mohanka said in a statement.
— Lance Baldo departed from Adaptive Biotechnologies, a Seattle-based biotech company, and joined San Francisco-based Freenome as its chief medical officer.
Baldo has more than 20 years of experience in healthcare leadership. Prior to his position as chief medical officer at Adaptive, Baldo was the head of US medical affairs for Genentech and the general manager for Roche Products New Zealand’s affiliate.
Freenome is a biotechnology company focused on detecting early-stage cancer in an individual’s blood plasma through artificial intelligence. The company landed $300 million in venture capital in a Series D round.